Arthur Harralson

Arthur Harralson is Professor and Chair of Biopharmaceutical Sciences and Pharmacogenomics at Shenandoah University, serving concurrently as Associate Dean for Research. As campus dean for Shenandoah's Inova Center for Personalized Health, he leads initiatives bridging pharmacogenomics and health equity.

His NIH-funded research through the African American Cardiovascular Pharmacogenomics Consortium (ACCOuNT) examines genetic contributors to cardiovascular drug response disparities. Core expertise includes:

• Warfarin and clopidogrel pharmacogenomics
• Race-specific dosing algorithms
• Implementation of precision medicine in underserved populations

Additional roles include FDA consultancy in clinical pharmacology and pharmacogenomics, influencing regulatory science. His $9.6M NIMHD grant supports investigations into cardiovascular health disparities affecting African Americans.